Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001510964-21-000012
Filing Date
2021-03-19
Accepted
2021-03-19 17:23:36
Documents
81
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cvsi-20201231.htm   iXBRL 10-K 1333571
2 EX-23.1 consentex231202010kng.htm EX-23.1 2463
3 EX-31.1 a302certificationceoex3112.htm EX-31.1 10728
4 EX-31.2 a302certificationcfoex3122.htm EX-31.2 10716
5 EX-32.1 a906certificationceoex3212.htm EX-32.1 5840
6 EX-32.2 a906certificationcfoex3222.htm EX-32.2 5828
  Complete submission text file 0001510964-21-000012.txt   6893781

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cvsi-20201231.xsd EX-101.SCH 43143
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cvsi-20201231_cal.xml EX-101.CAL 99553
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cvsi-20201231_def.xml EX-101.DEF 235763
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cvsi-20201231_lab.xml EX-101.LAB 659310
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cvsi-20201231_pre.xml EX-101.PRE 418808
12 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20201231_htm.xml XML 1046640
Mailing Address 10070 BARNES CANYON ROAD SAN DIEGO CA 92121
Business Address 10070 BARNES CANYON ROAD SAN DIEGO CA 92121 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

EIN.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54677 | Film No.: 21759159
SIC: 2834 Pharmaceutical Preparations